Cita APA

Fisher, V., Mateo Valderrama, J., Gjoerup, O. V., Madison, R. W., Graf, R., & Raskina, K. (2022). Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer.

Citación estilo Chicago

Fisher, Virginia, Joaquim Mateo Valderrama, Ole V. Gjoerup, Russell W. Madison, Ryon Graf, y Kira Raskina. Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer. 2022.

Cita MLA

Fisher, Virginia, et al. Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer. 2022.